These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 3781482)
21. Growth-promoting effect of growth hormone and low dose ethinyl estradiol in girls with Turner's syndrome. Vanderschueren-Lodeweyckx M; Massa G; Maes M; Craen M; van Vliet G; Heinrichs C; Malvaux P J Clin Endocrinol Metab; 1990 Jan; 70(1):122-6. PubMed ID: 2294126 [TBL] [Abstract][Full Text] [Related]
22. Effect of growth hormone administration frequency on 24-hour growth hormone profiles and levels of other growth related parameters in girls with Turner's syndrome. Dutch Working Group on Growth Hormone. van Teunenbroek A; de Muinck Keizer-Schrama SM; Stijnen T; Mouton JW; Blum WF; Mercado M; Baumann G; Drop SL Clin Endocrinol (Oxf); 1993 Jul; 39(1):77-84. PubMed ID: 7688672 [TBL] [Abstract][Full Text] [Related]
23. Growth hormone and craniofacial changes: preliminary data from studies in Turner's syndrome. Simmons KE Pediatrics; 1999 Oct; 104(4 Pt 2):1021-4. PubMed ID: 10506256 [TBL] [Abstract][Full Text] [Related]
24. Growth hormone therapy in Turner's syndrome: one versus two daily injections. De Schepper J; Craen M; Massa G; Heinrichs C; Maes M; Du Caju M; Rausin L; Bourguignon JP J Clin Endocrinol Metab; 1994 Aug; 79(2):489-94. PubMed ID: 8045968 [TBL] [Abstract][Full Text] [Related]
25. Effect of obesity on endogenous secretion of growth hormone in Turner's syndrome. Lu PW; Cowell CT; Jimenez M; Simpson JM; Silink M Arch Dis Child; 1991 Oct; 66(10):1184-90. PubMed ID: 1953000 [TBL] [Abstract][Full Text] [Related]
26. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol. Gravholt CH; Naeraa RW; Fisker S; Christiansen JS J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336 [TBL] [Abstract][Full Text] [Related]
27. Growth in Turner's syndrome: long term treatment with low dose ethinyl estradiol. Martínez A; Heinrich JJ; Domené H; Escobar ME; Jasper H; Montuori E; Bergadá G J Clin Endocrinol Metab; 1987 Aug; 65(2):253-7. PubMed ID: 3597706 [TBL] [Abstract][Full Text] [Related]
28. Growth hormone in short, slowly growing children and those with Turner's syndrome. Buchanan CR; Law CM; Milner RD Arch Dis Child; 1987 Sep; 62(9):912-6. PubMed ID: 3314726 [TBL] [Abstract][Full Text] [Related]
29. Growth hormone therapy in Turner's syndrome. O'Shea D; Powell D Ir Med J; 1992 Jun; 85(2):68-9. PubMed ID: 1628947 [TBL] [Abstract][Full Text] [Related]
31. Effect of growth hormone therapy on thyroid status of girls with Turner's syndrome. Massa G; de Zegher F; Vanderschueren-Lodeweyckx M Clin Endocrinol (Oxf); 1991 Mar; 34(3):205-9. PubMed ID: 2036729 [TBL] [Abstract][Full Text] [Related]
32. Insulin, insulin-like growth factor-binding protein-1, and sex hormone-binding globulin in patients with Turner's syndrome: course over age in untreated patients and effect of therapy with growth hormone alone and in combination with oxandrolone. Haeusler G; Schmitt K; Blümel P; Plöchl E; Waldhör T; Frisch H J Clin Endocrinol Metab; 1996 Feb; 81(2):536-41. PubMed ID: 8636264 [TBL] [Abstract][Full Text] [Related]
33. Turner's syndrome: treatment of 203 patients with recombinant human growth hormone for one year. A multicentre study. Takano K; Shizume K; Hibi I Acta Endocrinol (Copenh); 1989 May; 120(5):559-68. PubMed ID: 2658450 [TBL] [Abstract][Full Text] [Related]
34. Decreased metabolic clearance of endogenous growth hormone and specific alterations in the pulsatile mode of growth hormone secretion occur in prepubertal girls with Turner's syndrome. Genentech Collaborative Group. Veldhuis JD; Sotos JF; Sherman BM J Clin Endocrinol Metab; 1991 Nov; 73(5):1073-80. PubMed ID: 1939522 [TBL] [Abstract][Full Text] [Related]
35. Serum lipids, lipoprotein lp(a), and plasminogen activator inhibitor-1 in patients with Turner's syndrome before and during growth hormone and estrogen therapy. Lanes R; Gunczler P; Palacios A; Villaroel O Fertil Steril; 1997 Sep; 68(3):473-7. PubMed ID: 9314917 [TBL] [Abstract][Full Text] [Related]
36. What is the rationale for growth hormone therapy in Turner's syndrome? Cianfarani S; Vaccaro F; Boscherini B Lancet; 1994 Jul; 344(8915):114-5. PubMed ID: 7912351 [No Abstract] [Full Text] [Related]
37. Treatment of Turner's syndrome with methionyl human growth hormone for six months. Takano K; Hizuka N; Shizume K Acta Endocrinol (Copenh); 1986 May; 112(1):130-7. PubMed ID: 3521183 [TBL] [Abstract][Full Text] [Related]
38. Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome. The impact of sex hormone replacement. Gravholt CH; Naeraa RW; Nyholm B; Gerdes LU; Christiansen E; Schmitz O; Christiansen JS Diabetes Care; 1998 Jul; 21(7):1062-70. PubMed ID: 9653596 [TBL] [Abstract][Full Text] [Related]